Does LEDIPASVIR Cause Hyperbilirubinaemia? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Hyperbilirubinaemia have been filed in association with LEDIPASVIR (Harvoni). This represents 3.3% of all adverse event reports for LEDIPASVIR.
17
Reports of Hyperbilirubinaemia with LEDIPASVIR
3.3%
of all LEDIPASVIR reports
3
Deaths
1
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From LEDIPASVIR?
Of the 17 reports, 3 (17.6%) resulted in death, 1 (5.9%) required hospitalization.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does LEDIPASVIR Cause?
Pruritus (230)
Insomnia (225)
Diarrhoea (220)
Haemorrhagic stroke (218)
Tachycardia (218)
Fatigue (217)
Dizziness (216)
Headache (216)
Arthralgia (212)
Sepsis (212)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which LEDIPASVIR Alternatives Have Lower Hyperbilirubinaemia Risk?
LEDIPASVIR vs LEDIPASVIR\SOFOSBUVIR
LEDIPASVIR vs LEFLUNOMIDE
LEDIPASVIR vs LEMBOREXANT
LEDIPASVIR vs LENACAPAVIR
LEDIPASVIR vs LENALIDOMIDE